Press releases

The Guardian has reported that “a rightwing US group backing an anti-abortion campaigner whose case has become a new source of UK tensions with the Trump administration is significantly expanding activities and spending in Britain.

Responding to the claims published in The Telegraph that the “PM’s hopes of avoiding Donald Trump’s tariffs may hinge on case of pro-life activist arrested for peaceful protest”, Heidi Stewart, Chief Executive comments.

Commenting on the announcement from the Department of Health and Social Care that the ‘morning-after pill’ will be made available "free of charge at pharmacies on the NHS for the first time ever, ending the postcode lottery women face in accessing the medicine and reducing inequalities".

“BPAS is proud to have led the campaign to introduce these zones, proud to have spent nearly 60 years fighting for women’s health and rights, proud to provide abortion services in an overwhelmingly pro-choice country, and will always remain proud to stand against misogynistic and anti-democratic interference with British women’s reproductive rights by nefarious foreign extremists, whether they are the Vice President of the US or not.”

A new study has found that found “a shift in contraception use from more reliable hormonal methods of contraception to less reliable fertility awareness-based methods of contraception among abortion patients in England and Wales in 2018 and 2023.”

The British Pregnancy Advisory Service (BPAS) and Amnesty International UK have come together to host a screening of Zurawski v Texas, a film about a group of women denied abortions in Texas who band together with a fearless attorney to sue the state government. The screening will be followed by a panel discussion as we come together for an evening of resistance on the day of the Presidential inauguration.